SIMILAR PATTERNS OF AMINO ACIDS FOR 4DQB_B_017B101

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bou 4,5-DIOXYGENASE BETA
CHAIN


(Sphingomonas
paucimobilis)
PF02900
(LigB)
5 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
0.94A 4dqbA-1bouB:
undetectable
4dqbA-1bouB:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e69 CHROMOSOME
SEGREGATION SMC
PROTEIN


(Thermotoga
maritima)
PF02463
(SMC_N)
5 LEU A   6
VAL A  93
ILE A 117
GLY A  49
VAL A  80
None
0.92A 4dqbA-1e69A:
undetectable
4dqbA-1e69A:
17.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ekq HYDROXYETHYLTHIAZOLE
KINASE


(Bacillus
subtilis)
PF02110
(HK)
5 LEU A 215
ALA A 119
VAL A 204
GLY A 122
ILE A 167
None
0.92A 4dqbA-1ekqA:
undetectable
4dqbA-1ekqA:
19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gae D-GLYCERALDEHYDE-3-P
HOSPHATE
DEHYDROGENASE


(Escherichia
coli)
PF00044
(Gp_dh_N)
PF02800
(Gp_dh_C)
5 ALA O  19
VAL O   3
ILE O 325
ILE O  11
ILE O  27
None
None
None
NAD  O 336 (-3.9A)
None
0.85A 4dqbA-1gaeO:
undetectable
4dqbA-1gaeO:
16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gq8 PECTINESTERASE

(Daucus carota)
PF01095
(Pectinesterase)
5 LEU A 167
VAL A 235
ILE A 240
GLY A 207
ILE A 201
None
0.85A 4dqbA-1gq8A:
undetectable
4dqbA-1gq8A:
14.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
1.34A 4dqbA-1hvcA:
14.1
4dqbA-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.54A 4dqbA-1hvcA:
14.1
4dqbA-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.50A 4dqbA-1hvcA:
14.1
4dqbA-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
1.03A 4dqbA-1hvcA:
14.1
4dqbA-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  48
VAL A  82
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.4A)
A79  A 800 (-3.6A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
1.11A 4dqbA-1hvcA:
14.1
4dqbA-1hvcA:
46.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1iq7 OVOTRANSFERRIN

(Gallus gallus)
PF00405
(Transferrin)
5 ARG A 344
LEU A 607
ALA A 391
GLY A 387
ILE A 604
None
0.94A 4dqbA-1iq7A:
undetectable
4dqbA-1iq7A:
14.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nfg D-HYDANTOINASE

(Ralstonia
pickettii)
PF00449
(Urease_alpha)
PF01979
(Amidohydro_1)
5 ALA A  19
VAL A  49
ILE A   5
GLY A  22
ILE A  10
None
0.90A 4dqbA-1nfgA:
undetectable
4dqbA-1nfgA:
11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nov NODAMURA VIRUS COAT
PROTEINS


(Nodamura virus)
PF01829
(Peptidase_A6)
5 LEU A 113
ALA A 173
VAL A 190
VAL A 301
ILE A 299
None
0.89A 4dqbA-1novA:
undetectable
4dqbA-1novA:
15.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
None
0.78A 4dqbA-1q9pA:
10.0
4dqbA-1q9pA:
96.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qap QUINOLINIC ACID
PHOSPHORIBOSYLTRANSF
ERASE


(Salmonella
enterica)
PF01729
(QRPTase_C)
PF02749
(QRPTase_N)
5 LEU A 148
ALA A 270
VAL A 257
VAL A 279
ILE A 277
None
0.89A 4dqbA-1qapA:
undetectable
4dqbA-1qapA:
15.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
None
1.46A 4dqbA-1sivA:
18.5
4dqbA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.51A 4dqbA-1sivA:
18.5
4dqbA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
None
0.77A 4dqbA-1sivA:
18.5
4dqbA-1sivA:
51.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1szq 2-METHYLCITRATE
DEHYDRATASE


(Escherichia
coli)
PF03972
(MmgE_PrpD)
5 LEU A 409
ALA A 299
ILE A 354
VAL A 320
ILE A 407
None
0.91A 4dqbA-1szqA:
undetectable
4dqbA-1szqA:
13.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uaa PROTEIN
(ATP-DEPENDENT DNA
HELICASE REP.)


(Escherichia
coli)
PF00580
(UvrD-helicase)
PF13361
(UvrD_C)
5 LEU A 630
ALA A 596
ILE A 291
ILE A 283
PRO A 634
None
0.87A 4dqbA-1uaaA:
undetectable
4dqbA-1uaaA:
10.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1usy ATP
PHOSPHORIBOSYLTRANSF
ERASE REGULATORY
SUBUNIT


(Thermotoga
maritima)
PF13393
(tRNA-synt_His)
5 ALA C 251
VAL C 114
ILE C 238
VAL C 109
ILE C 113
None
0.71A 4dqbA-1usyC:
undetectable
4dqbA-1usyC:
16.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v5f PYRUVATE OXIDASE

(Aerococcus
viridans)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
5 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.92A 4dqbA-1v5fA:
undetectable
4dqbA-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vfw PROTEIN (FUSION
PROTEIN CONSISTING
OF KINESIN-LIKE
PROTEIN KIF1A,
KINESIN HEAVY CHAIN
ISOFORM 5C AND A HIS
TAG


(Mus musculus)
PF00225
(Kinesin)
5 ARG A  11
ALA A 326
ILE A 119
VAL A  73
ILE A  77
ANP  A 500 (-3.7A)
None
None
None
None
0.94A 4dqbA-1vfwA:
undetectable
4dqbA-1vfwA:
13.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vkn N-ACETYL-GAMMA-GLUTA
MYL-PHOSPHATE
REDUCTASE


(Thermotoga
maritima)
PF01118
(Semialdhyde_dh)
PF02774
(Semialdhyde_dhC)
5 LEU A  70
VAL A 139
ILE A 120
VAL A  89
ILE A  91
None
0.90A 4dqbA-1vknA:
undetectable
4dqbA-1vknA:
16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wdt ELONGATION FACTOR G
HOMOLOG


(Thermus
thermophilus)
PF00009
(GTP_EFTU)
PF00679
(EFG_C)
PF03764
(EFG_IV)
PF14492
(EFG_II)
5 ALA A 237
VAL A 213
GLY A 231
VAL A 208
ILE A 212
None
0.94A 4dqbA-1wdtA:
undetectable
4dqbA-1wdtA:
8.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wsv AMINOMETHYLTRANSFERA
SE


(Homo sapiens)
PF01571
(GCV_T)
PF08669
(GCV_T_C)
5 LEU A 152
VAL A 192
GLY A 166
VAL A 207
ILE A 205
LEU  A 152 ( 0.6A)
VAL  A 192 ( 0.6A)
GLY  A 166 ( 0.0A)
VAL  A 207 ( 0.6A)
ILE  A 205 ( 0.4A)
0.80A 4dqbA-1wsvA:
undetectable
4dqbA-1wsvA:
14.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wu2 MOLYBDOPTERIN
BIOSYNTHESIS MOEA
PROTEIN


(Pyrococcus
horikoshii)
PF00994
(MoCF_biosynth)
PF03453
(MoeA_N)
PF03454
(MoeA_C)
5 LEU A 376
ALA A 374
VAL A 328
VAL A 391
ILE A 393
None
0.90A 4dqbA-1wu2A:
undetectable
4dqbA-1wu2A:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xqi NUCLEOSIDE
DIPHOSPHATE KINASE


(Pyrobaculum
aerophilum)
PF00334
(NDK)
6 ARG A 165
ASP A  25
ALA A  26
VAL A 171
ILE A 148
ILE A 154
None
1.25A 4dqbA-1xqiA:
undetectable
4dqbA-1xqiA:
23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cev PROTEIN (ARGINASE)

([Bacillus]
caldovelox)
PF00491
(Arginase)
5 LEU A  36
GLY A  47
ILE A   7
VAL A  32
ILE A  33
None
0.93A 4dqbA-2cevA:
undetectable
4dqbA-2cevA:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cun PHOSPHOGLYCERATE
KINASE


(Pyrococcus
horikoshii)
PF00162
(PGK)
5 LEU A 316
ILE A 376
GLY A 357
VAL A 343
ILE A 347
None
0.87A 4dqbA-2cunA:
undetectable
4dqbA-2cunA:
15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eig LECTIN

(Lotus
tetragonolobus)
PF00139
(Lectin_legB)
5 LEU A 146
VAL A 117
ILE A 163
VAL A 140
ILE A 138
None
0.86A 4dqbA-2eigA:
undetectable
4dqbA-2eigA:
18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fb5 HYPOTHETICAL
MEMBRANE SPANNING
PROTEIN


(Bacillus cereus)
PF02457
(DisA_N)
PF10372
(YojJ)
5 LEU A 183
ALA A  94
VAL A 138
ILE A 126
ILE A  96
None
0.92A 4dqbA-2fb5A:
undetectable
4dqbA-2fb5A:
15.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  53
PRO A  86
ILE A  89
LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
0.71A 4dqbA-2fmbA:
15.0
4dqbA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
0.99A 4dqbA-2fmbA:
15.0
4dqbA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
9 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.65A 4dqbA-2fmbA:
15.0
4dqbA-2fmbA:
34.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g3n ALPHA-GLUCOSIDASE

(Sulfolobus
solfataricus)
PF01055
(Glyco_hydro_31)
PF13802
(Gal_mutarotas_2)
5 LEU A   4
VAL A 145
ILE A 140
VAL A  15
ILE A  17
None
0.83A 4dqbA-2g3nA:
undetectable
4dqbA-2g3nA:
10.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ggq 401AA LONG
HYPOTHETICAL
GLUCOSE-1-PHOSPHATE
THYMIDYLYLTRANSFERAS
E


(Sulfurisphaera
tokodaii)
PF00132
(Hexapep)
PF00483
(NTP_transferase)
6 LEU A 355
VAL A 375
ILE A 377
GLY A 360
ILE A  17
VAL A 341
None
1.31A 4dqbA-2ggqA:
undetectable
4dqbA-2ggqA:
14.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2i6t UBIQUITIN-CONJUGATIN
G ENZYME E2-LIKE
ISOFORM A


(Homo sapiens)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
5 LEU A 210
VAL A 248
ILE A 401
VAL A 187
ILE A 185
None
0.87A 4dqbA-2i6tA:
undetectable
4dqbA-2i6tA:
15.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2lnv GENERAL SECRETION
PATHWAY PROTEIN C


(Dickeya
dadantii)
PF11356
(T2SSC)
5 LEU A 145
GLY A  99
PRO A 129
VAL A 128
ILE A 135
None
0.90A 4dqbA-2lnvA:
undetectable
4dqbA-2lnvA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p3e DIAMINOPIMELATE
DECARBOXYLASE


(Aquifex
aeolicus)
PF00278
(Orn_DAP_Arg_deC)
PF02784
(Orn_Arg_deC_N)
5 ALA A 355
VAL A 371
GLY A 345
ILE A 308
ILE A 328
None
0.76A 4dqbA-2p3eA:
undetectable
4dqbA-2p3eA:
12.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q0l THIOREDOXIN
REDUCTASE


(Helicobacter
pylori)
PF07992
(Pyr_redox_2)
5 ALA A   5
VAL A  84
ILE A 108
GLY A   8
ILE A  93
None
None
None
FAD  A 400 (-3.2A)
None
0.82A 4dqbA-2q0lA:
undetectable
4dqbA-2q0lA:
15.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
AB1  A 501 ( 4.7A)
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.64A 4dqbA-2rkfA:
20.7
4dqbA-2rkfA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-4.2A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.73A 4dqbA-2rkfA:
20.7
4dqbA-2rkfA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2v5i SALMONELLA
TYPHIMURIUM DB7155
BACTERIOPHAGE DET7
TAILSPIKE


(unidentified
phage)
PF09251
(PhageP22-tail)
5 ALA A 548
ILE A 580
ILE A 536
VAL A 543
ILE A 546
None
0.91A 4dqbA-2v5iA:
undetectable
4dqbA-2v5iA:
14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wia FERROUS IRON
TRANSPORT PROTEIN B


(Klebsiella
pneumoniae)
PF02421
(FeoB_N)
5 LEU A   8
VAL A 116
GLY A 155
VAL A  92
ILE A  90
None
0.90A 4dqbA-2wiaA:
undetectable
4dqbA-2wiaA:
14.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y23 MYOMESIN

(Homo sapiens)
PF07679
(I-set)
5 ASP A1401
GLY A1409
ILE A1410
VAL A1428
ILE A1389
None
0.83A 4dqbA-2y23A:
undetectable
4dqbA-2y23A:
17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ynm LIGHT-INDEPENDENT
PROTOCHLOROPHYLLIDE
REDUCTASE
IRON-SULFUR
ATP-BINDING PROTEIN
LIGHT-INDEPENDENT
PROTOCHLOROPHYLLIDE
REDUCTASE SUBUNIT N


(Prochlorococcus
marinus)
PF00142
(Fer4_NifH)
PF00148
(Oxidored_nitro)
5 LEU A  87
ALA C  71
GLY A 126
VAL A  83
ILE A  84
None
None
SF4  A1302 (-3.9A)
None
EPE  A1298 (-4.9A)
0.92A 4dqbA-2ynmA:
undetectable
4dqbA-2ynmA:
18.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z2u UPF0026 PROTEIN
MJ0257


(Methanocaldococcus
jannaschii)
PF04055
(Radical_SAM)
PF08608
(Wyosine_form)
5 VAL A 161
ILE A 174
ILE A 151
VAL A 131
ILE A 133
None
0.86A 4dqbA-2z2uA:
undetectable
4dqbA-2z2uA:
16.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b54 NUCLEOSIDE
DIPHOSPHATE KINASE


(Saccharomyces
cerevisiae)
PF00334
(NDK)
6 ARG A  19
LEU A  21
ILE A  91
GLY A 103
VAL A 117
ILE A  25
None
1.21A 4dqbA-3b54A:
undetectable
4dqbA-3b54A:
24.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dc8 DIHYDROPYRIMIDINASE

(Sinorhizobium
meliloti)
PF01979
(Amidohydro_1)
5 LEU A  41
VAL A  21
ILE A 382
GLY A  51
ILE A   5
None
0.78A 4dqbA-3dc8A:
undetectable
4dqbA-3dc8A:
11.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dkp PROBABLE
ATP-DEPENDENT RNA
HELICASE DDX52


(Homo sapiens)
PF00270
(DEAD)
5 LEU A 205
ASP A 155
ILE A 160
VAL A 374
ILE A 372
None
0.82A 4dqbA-3dkpA:
undetectable
4dqbA-3dkpA:
15.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eef N-CARBAMOYLSARCOSINE
AMIDASE RELATED
PROTEIN


(Thermoplasma
acidophilum)
PF00857
(Isochorismatase)
6 ALA A 144
VAL A   7
ILE A  35
ILE A 171
VAL A 114
ILE A 116
None
1.46A 4dqbA-3eefA:
undetectable
4dqbA-3eefA:
19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fkj PUTATIVE
PHOSPHOSUGAR
ISOMERASES


(Salmonella
enterica)
PF01380
(SIS)
5 ALA A  99
ILE A  75
GLY A 102
ILE A 118
ILE A  15
None
0.81A 4dqbA-3fkjA:
undetectable
4dqbA-3fkjA:
13.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3krz NADH:FLAVIN
OXIDOREDUCTASE/NADH
OXIDASE


(Thermoanaerobacter
pseudethanolicus)
PF00724
(Oxidored_FMN)
5 LEU A 101
VAL A 215
ILE A 239
VAL A 160
ILE A 162
None
0.72A 4dqbA-3krzA:
undetectable
4dqbA-3krzA:
15.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kzh PROBABLE SUGAR
KINASE


(Clostridium
perfringens)
PF00294
(PfkB)
5 ASP A 166
VAL A 141
ILE A  48
GLY A 262
ILE A 164
BGC  A 329 (-3.8A)
None
None
None
None
0.92A 4dqbA-3kzhA:
undetectable
4dqbA-3kzhA:
14.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mgl SULFATE PERMEASE
FAMILY PROTEIN


(Vibrio cholerae)
PF01740
(STAS)
5 LEU A 475
VAL A 532
GLY A 522
VAL A 505
ILE A 507
None
0.73A 4dqbA-3mglA:
undetectable
4dqbA-3mglA:
23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mst PUTATIVE NITRATE
TRANSPORT PROTEIN


(Thermoplasma
volcanium)
PF12916
(DUF3834)
6 ALA A 171
ILE A 163
GLY A 191
ILE A 192
PRO A  10
ILE A 174
None
None
None
None
ACT  A 232 (-4.6A)
None
1.21A 4dqbA-3mstA:
undetectable
4dqbA-3mstA:
19.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mwe ATP-CITRATE SYNTHASE

(Homo sapiens)
PF16114
(Citrate_bind)
5 LEU A 217
VAL A 121
ILE A 185
GLY A 187
ILE A 202
None
0.88A 4dqbA-3mweA:
undetectable
4dqbA-3mweA:
12.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
None
1.49A 4dqbA-3mwsA:
19.7
4dqbA-3mwsA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
None
0.57A 4dqbA-3mwsA:
19.7
4dqbA-3mwsA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  48
PRO A  81
ILE A  84
None
0.94A 4dqbA-3mwsA:
19.7
4dqbA-3mwsA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3omn CYTOCHROME C
OXIDASE, AA3 TYPE,
SUBUNIT I


(Rhodobacter
sphaeroides)
PF00115
(COX1)
5 LEU A 243
ALA A 205
ILE A 232
GLY A 117
ILE A 239
None
0.94A 4dqbA-3omnA:
undetectable
4dqbA-3omnA:
11.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3p4g ANTIFREEZE PROTEIN

(Marinomonas
primoryensis)
no annotation 5 LEU A 162
ALA A 136
ASP A 122
VAL A 124
ILE A 143
None
CA  A 406 (-4.5A)
CA  A 404 ( 2.4A)
None
None
0.90A 4dqbA-3p4gA:
undetectable
4dqbA-3p4gA:
13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pmo UDP-3-O-[3-HYDROXYMY
RISTOYL] GLUCOSAMINE
N-ACYLTRANSFERASE


(Pseudomonas
aeruginosa)
PF00132
(Hexapep)
PF04613
(LpxD)
5 ALA A 119
VAL A 115
ILE A 103
GLY A 122
ILE A 133
None
0.88A 4dqbA-3pmoA:
undetectable
4dqbA-3pmoA:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3psg PEPSINOGEN

(Sus scrofa)
PF00026
(Asp)
PF07966
(A1_Propeptide)
5 LEU A 155
ASP A 303
GLY A  34
VAL A 153
ILE A 306
None
0.93A 4dqbA-3psgA:
5.8
4dqbA-3psgA:
18.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pz2 GERANYLGERANYL
TRANSFERASE TYPE-2
SUBUNIT BETA


(Rattus
norvegicus)
PF00432
(Prenyltrans)
5 LEU B 298
VAL B  56
ILE B  27
GLY B 276
ILE B 295
None
0.90A 4dqbA-3pz2B:
undetectable
4dqbA-3pz2B:
14.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qtg PYRUVATE KINASE

(Pyrobaculum
aerophilum)
PF00224
(PK)
PF02887
(PK_C)
6 LEU A  23
ALA A  52
VAL A  79
ILE A 190
VAL A  45
ILE A  47
None
1.42A 4dqbA-3qtgA:
undetectable
4dqbA-3qtgA:
12.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 LEU A  30
ASP A  32
ALA A  35
VAL A  39
GLY A  56
None
3TL  A 126 (-2.4A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-3.4A)
0.55A 4dqbA-3slzA:
11.0
4dqbA-3slzA:
25.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 LEU A  30
ASP A  32
ALA A  35
VAL A  39
PRO A  89
None
3TL  A 126 (-2.4A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-4.0A)
0.72A 4dqbA-3slzA:
11.0
4dqbA-3slzA:
25.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sze SERINE PROTEASE ESPP

(Escherichia
coli)
PF02395
(Peptidase_S6)
5 ALA A 723
ILE A 708
ILE A 655
VAL A 648
ILE A 667
None
0.92A 4dqbA-3szeA:
undetectable
4dqbA-3szeA:
7.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
SO4  A 101 (-3.8A)
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.88A 4dqbA-3t3cA:
18.3
4dqbA-3t3cA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
SO4  A 101 (-3.8A)
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
None
017  A 201 (-4.0A)
None
0.97A 4dqbA-3t3cA:
18.3
4dqbA-3t3cA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
017  A 201 ( 4.8A)
None
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.56A 4dqbA-3ttpA:
19.4
4dqbA-3ttpA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.4A)
None
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.84A 4dqbA-3ttpA:
19.4
4dqbA-3ttpA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u24 PUTATIVE LIPOPROTEIN

(Shewanella
oneidensis)
PF05960
(DUF885)
6 ARG A 554
LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.25A 4dqbA-3u24A:
undetectable
4dqbA-3u24A:
11.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
None
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
0.74A 4dqbA-3u7sA:
19.7
4dqbA-3u7sA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
None
0.68A 4dqbA-3uhlA:
15.9
4dqbA-3uhlA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v70 GTPASE IMAP FAMILY
MEMBER 1


(Homo sapiens)
PF04548
(AIG1)
5 LEU A 115
VAL A  81
GLY A 102
VAL A  33
ILE A  31
None
0.90A 4dqbA-3v70A:
undetectable
4dqbA-3v70A:
17.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4avo BETA-1,4-EXOCELLULAS
E


(Thermobifida
fusca)
PF01341
(Glyco_hydro_6)
5 LEU A 178
GLY A 313
ILE A 315
VAL A 217
ILE A 219
None
0.78A 4dqbA-4avoA:
undetectable
4dqbA-4avoA:
14.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4d7e L-LYS MONOOXYGENASE

(Nocardia
farcinica)
PF13434
(K_oxygenase)
5 ALA A  17
VAL A 124
ILE A  66
ILE A  82
ILE A 128
None
0.94A 4dqbA-4d7eA:
undetectable
4dqbA-4d7eA:
14.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4doi CHALCONE--FLAVONONE
ISOMERASE 1


(Arabidopsis
thaliana)
PF02431
(Chalcone)
5 VAL A  63
ILE A 203
GLY A 207
VAL A 106
ILE A 104
None
None
None
NO3  A 301 (-4.8A)
None
0.94A 4dqbA-4doiA:
undetectable
4dqbA-4doiA:
19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f4o HAPTOGLOBIN

(Sus scrofa)
PF00089
(Trypsin)
5 LEU C 138
VAL C 177
ILE C 158
ILE C 121
ILE C 191
None
0.94A 4dqbA-4f4oC:
undetectable
4dqbA-4f4oC:
17.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f82 THIOREDOXIN
REDUCTASE


(Burkholderia
cenocepacia)
PF08534
(Redoxin)
6 LEU A  13
ALA A 111
VAL A  83
GLY A 117
ILE A   2
VAL A  81
None
1.08A 4dqbA-4f82A:
undetectable
4dqbA-4f82A:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fe9 OUTER MEMBRANE
PROTEIN SUSF


(Bacteroides
thetaiotaomicron)
PF16411
(SusF_SusE)
PF17142
(DUF5115)
5 LEU A 387
ILE A 453
GLY A 482
VAL A 427
ILE A 429
None
0.92A 4dqbA-4fe9A:
undetectable
4dqbA-4fe9A:
13.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fmz INTERNALIN

(Listeria
monocytogenes)
PF12354
(Internalin_N)
PF12799
(LRR_4)
PF13855
(LRR_8)
5 LEU A 343
ILE A 356
ILE A 310
VAL A 339
ILE A 340
None
EDO  A 405 (-3.8A)
None
None
None
0.73A 4dqbA-4fmzA:
undetectable
4dqbA-4fmzA:
16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g1g MATRIX PROTEIN

(Avian
avulavirus 1)
PF00661
(Matrix)
5 LEU A 322
ALA A 320
ILE A 314
VAL A 208
ILE A 210
None
0.92A 4dqbA-4g1gA:
undetectable
4dqbA-4g1gA:
14.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gni PUTATIVE HEAT SHOCK
PROTEIN


(Chaetomium
thermophilum)
PF00012
(HSP70)
5 LEU A 375
ASP A 211
VAL A 209
GLY A 393
ILE A 349
None
MG  A 501 ( 3.9A)
None
None
None
0.88A 4dqbA-4gniA:
undetectable
4dqbA-4gniA:
14.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4h0o ACETATE KINASE

(Entamoeba
histolytica)
PF00871
(Acetate_kinase)
5 LEU A 183
GLY A 208
ILE A 195
VAL A 179
ILE A 180
None
0.90A 4dqbA-4h0oA:
undetectable
4dqbA-4h0oA:
12.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hv4 UDP-N-ACETYLMURAMATE
--L-ALANINE LIGASE


(Yersinia pestis)
PF01225
(Mur_ligase)
PF02875
(Mur_ligase_C)
PF08245
(Mur_ligase_M)
5 LEU A 348
VAL A 376
ILE A 453
VAL A 462
ILE A 460
None
0.89A 4dqbA-4hv4A:
undetectable
4dqbA-4hv4A:
13.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hyk DNA POLYMERASE IV

(Sulfolobus
acidocaldarius)
PF00817
(IMS)
PF11798
(IMS_HHH)
5 LEU A 109
VAL A 145
ILE A 123
VAL A   6
ILE A   4
None
0.92A 4dqbA-4hykA:
undetectable
4dqbA-4hykA:
15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4inj LMO1638 PROTEIN

(Listeria
monocytogenes)
PF02016
(Peptidase_S66)
5 LEU A 162
ALA A 309
GLY A 306
ILE A 305
ILE A 321
None
0.86A 4dqbA-4injA:
undetectable
4dqbA-4injA:
16.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4je0 SER-ASP RICH
FIBRINOGEN/BONE
SIALOPROTEIN-BINDING
PROTEIN SDRD


(Staphylococcus
aureus)
PF10425
(SdrG_C_C)
5 LEU A  31
VAL A  59
ILE A  94
VAL A  57
ILE A 116
None
0.87A 4dqbA-4je0A:
undetectable
4dqbA-4je0A:
15.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kpo NUCLEOSIDE
N-RIBOHYDROLASE 3


(Zea mays)
PF01156
(IU_nuc_hydro)
5 LEU A  29
ASP A   6
ILE A 129
VAL A 118
ILE A   4
None
0.85A 4dqbA-4kpoA:
undetectable
4dqbA-4kpoA:
19.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kpo NUCLEOSIDE
N-RIBOHYDROLASE 3


(Zea mays)
PF01156
(IU_nuc_hydro)
5 LEU A  29
ASP A   6
VAL A 120
ILE A 129
ILE A   4
None
0.91A 4dqbA-4kpoA:
undetectable
4dqbA-4kpoA:
19.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  48
PRO A  81
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-4.8A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.93A 4dqbA-4njvA:
20.5
4dqbA-4njvA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
None
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.58A 4dqbA-4njvA:
20.5
4dqbA-4njvA:
82.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nqy ISOPROPYLMALATE/CITR
AMALATE ISOMERASE
LARGE SUBUNIT


(Methanocaldococcus
jannaschii)
PF00330
(Aconitase)
5 VAL A 177
ILE A 164
GLY A 166
VAL A 172
ILE A 272
None
0.91A 4dqbA-4nqyA:
undetectable
4dqbA-4nqyA:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o99 ACETYL-COA
ACETYLTRANSFERASE


(Cupriavidus
necator)
PF00108
(Thiolase_N)
PF02803
(Thiolase_C)
6 ALA A  69
VAL A  33
GLY A  54
ILE A  84
VAL A 111
ILE A  34
None
1.34A 4dqbA-4o99A:
undetectable
4dqbA-4o99A:
15.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p8r GLYCERALDEHYDE
3-PHOSPHATE
DEHYDROGENASE,
CYTOSOLIC


(Trypanosoma
brucei)
PF00044
(Gp_dh_N)
PF02800
(Gp_dh_C)
5 ALA A  21
VAL A   5
ILE A 326
ILE A  13
ILE A  29
MG  A 401 (-4.5A)
None
None
NAD  A 400 (-4.3A)
None
0.86A 4dqbA-4p8rA:
undetectable
4dqbA-4p8rA:
15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pfw ABC TRANSPORTER
SUBSTRATE-BINDING
PROTEIN


(Thermotoga
maritima)
PF00496
(SBP_bac_5)
5 ALA A 393
ASP A 389
GLY A 279
ILE A 509
ILE A 307
None
BMA  A 607 ( 2.9A)
None
None
None
0.93A 4dqbA-4pfwA:
undetectable
4dqbA-4pfwA:
11.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e69 CHROMOSOME
SEGREGATION SMC
PROTEIN


(Thermotoga
maritima)
PF02463
(SMC_N)
5 LEU A1092
GLY A1085
ALA A1087
GLY A1043
VAL A1026
None
0.95A 4dqbB-1e69A:
undetectable
4dqbB-1e69A:
17.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  48
A79  A 800 ( 3.8A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 (-3.6A)
0.88A 4dqbB-1hvcA:
13.8
4dqbB-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  48
VAL A  82
A79  A 800 ( 4.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 (-4.1A)
A79  A 800 (-4.5A)
0.88A 4dqbB-1hvcA:
13.8
4dqbB-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
1.15A 4dqbB-1hvcA:
13.8
4dqbB-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
1.16A 4dqbB-1hvcA:
13.8
4dqbB-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 (-3.8A)
0.84A 4dqbB-1hvcA:
13.8
4dqbB-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.6A)
0.87A 4dqbB-1hvcA:
13.8
4dqbB-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
VAL A  82
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 (-4.5A)
0.57A 4dqbB-1hvcA:
13.8
4dqbB-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
VAL A  82
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 (-4.5A)
0.52A 4dqbB-1hvcA:
13.8
4dqbB-1hvcA:
46.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mb9 BETA-LACTAM
SYNTHETASE


(Streptomyces
clavuligerus)
PF00733
(Asn_synthase)
PF13537
(GATase_7)
5 LEU A 405
GLY A 349
ALA A 350
GLY A 356
VAL A 409
None
None
MG  A 604 ( 4.8A)
None
None
0.99A 4dqbB-1mb9A:
undetectable
4dqbB-1mb9A:
12.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1o5w AMINE OXIDASE
[FLAVIN-CONTAINING]
A


(Rattus
norvegicus)
PF01593
(Amino_oxidase)
5 LEU A 233
ALA A  29
VAL A 238
GLY A  22
ILE A  23
None
None
None
FAD  A 652 (-3.4A)
FAD  A 652 (-4.8A)
0.84A 4dqbB-1o5wA:
undetectable
4dqbB-1o5wA:
12.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pqu ASPARTATE-SEMIALDEHY
DE DEHYDROGENASE


(Haemophilus
influenzae)
PF01118
(Semialdhyde_dh)
PF02774
(Semialdhyde_dhC)
5 LEU A 354
ALA A  98
ASP A  97
GLY A   8
VAL A  16
NAP  A1372 (-4.3A)
NAP  A1372 ( 4.0A)
None
NAP  A1372 (-3.1A)
None
0.98A 4dqbB-1pquA:
undetectable
4dqbB-1pquA:
15.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
None
0.52A 4dqbB-1q9pA:
10.0
4dqbB-1q9pA:
96.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s1d APYRASE

(Homo sapiens)
PF06079
(Apyrase)
5 GLY A 157
ALA A 144
ASP A 112
ILE A 101
VAL A 129
None
None
GP2  A4001 (-4.2A)
TRS  A5001 ( 4.9A)
None
0.87A 4dqbB-1s1dA:
undetectable
4dqbB-1s1dA:
16.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s2t PHOSPHOENOLPYRUVATE
PHOSPHOMUTASE


(Mytilus edulis)
PF13714
(PEP_mutase)
5 LEU A  71
ALA A  32
GLY A  42
ILE A  23
VAL A 108
None
0.78A 4dqbB-1s2tA:
undetectable
4dqbB-1s2tA:
19.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
None
0.79A 4dqbB-1sivA:
18.1
4dqbB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.17A 4dqbB-1sivA:
18.1
4dqbB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
0.53A 4dqbB-1sivA:
18.1
4dqbB-1sivA:
51.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1svv THREONINE ALDOLASE

(Leishmania
major)
PF01212
(Beta_elim_lyase)
5 LEU A 265
GLY A 219
ALA A 214
GLY A 254
ILE A 255
None
1.00A 4dqbB-1svvA:
undetectable
4dqbB-1svvA:
15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tlg POLYANDROCARPA
LECTIN


(Polyandrocarpa
misakiensis)
PF00059
(Lectin_C)
5 LEU A  81
GLY A  56
ALA A  57
ASP A  58
GLY A  72
None
0.85A 4dqbB-1tlgA:
undetectable
4dqbB-1tlgA:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1to3 PUTATIVE ALDOLASE
YIHT


(Salmonella
enterica)
PF01791
(DeoC)
5 LEU A 184
GLY A 188
ALA A 189
ASP A 190
VAL A 127
None
0.85A 4dqbB-1to3A:
undetectable
4dqbB-1to3A:
16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u2e 2-HYDROXY-6-KETONONA
-2,4-DIENEDIOIC ACID
HYDROLASE


(Escherichia
coli)
PF12697
(Abhydrolase_6)
5 LEU A 281
GLY A  61
ALA A  60
ILE A  54
VAL A 277
None
0.94A 4dqbB-1u2eA:
undetectable
4dqbB-1u2eA:
20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wwk PHOSPHOGLYCERATE
DEHYDROGENASE


(Pyrococcus
horikoshii)
PF00389
(2-Hacid_dh)
PF02826
(2-Hacid_dh_C)
5 LEU A 302
GLY A  21
ALA A  20
ILE A  14
VAL A 298
None
0.87A 4dqbB-1wwkA:
undetectable
4dqbB-1wwkA:
18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yr2 PROLYL
OLIGOPEPTIDASE


(Novosphingobium
capsulatum)
PF00326
(Peptidase_S9)
PF02897
(Peptidase_S9_N)
5 GLY A 539
ALA A 538
ASP A 537
GLY A 529
VAL A 474
None
0.89A 4dqbB-1yr2A:
undetectable
4dqbB-1yr2A:
10.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bkl PROLYL ENDOPEPTIDASE

(Myxococcus
xanthus)
PF00326
(Peptidase_S9)
PF02897
(Peptidase_S9_N)
5 GLY A 497
ALA A 496
ASP A 495
GLY A 487
VAL A 430
None
0.93A 4dqbB-2bklA:
undetectable
4dqbB-2bklA:
9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cvj THIOREDOXIN
REDUCTASE RELATED
PROTEIN


(Thermus
thermophilus)
PF00890
(FAD_binding_2)
PF07992
(Pyr_redox_2)
5 LEU A 170
GLY A  24
ALA A  23
ASP A 177
VAL A 164
None
0.95A 4dqbB-2cvjA:
undetectable
4dqbB-2cvjA:
20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2d1q LUCIFERIN
4-MONOOXYGENASE


(Luciola
cruciata)
PF00501
(AMP-binding)
PF13193
(AMP-binding_C)
5 LEU A 514
GLY A 470
ALA A 469
ASP A 468
VAL A 504
None
0.86A 4dqbB-2d1qA:
undetectable
4dqbB-2d1qA:
12.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dws COPPER-CONTAINING
NITRITE REDUCTASE


(Rhodobacter
sphaeroides)
PF00394
(Cu-oxidase)
PF07732
(Cu-oxidase_3)
5 LEU A  90
GLY A 254
ALA A 255
GLY A 347
ILE A 250
None
0.86A 4dqbB-2dwsA:
undetectable
4dqbB-2dwsA:
17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ewn BIRA BIFUNCTIONAL
PROTEIN


(Escherichia
coli)
PF02237
(BPL_C)
PF03099
(BPL_LplA_LipB)
PF08279
(HTH_11)
5 LEU A 131
GLY A 186
ALA A 185
GLY A 154
ILE A 153
None
BTX  A 501 (-3.3A)
None
None
None
0.91A 4dqbB-2ewnA:
undetectable
4dqbB-2ewnA:
19.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
0.78A 4dqbB-2fmbA:
15.2
4dqbB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
VAL A  87
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
0.56A 4dqbB-2fmbA:
15.2
4dqbB-2fmbA:
34.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gn1 THREONINE
DEHYDRATASE
CATABOLIC


(Salmonella
enterica)
PF00291
(PALP)
6 GLY A 285
ALA A 284
ASP A 236
GLY A 184
ILE A 183
VAL A 261
LLP  A  58 ( 4.8A)
LLP  A  58 ( 3.4A)
None
LLP  A  58 ( 3.5A)
None
None
1.38A 4dqbB-2gn1A:
undetectable
4dqbB-2gn1A:
14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iss PYRIDOXAL
BIOSYNTHESIS LYASE
PDXS


(Thermotoga
maritima)
PF01680
(SOR_SNZ)
5 LEU A 224
GLY A 229
ALA A 230
ASP A 231
VAL A 158
None
0.92A 4dqbB-2issA:
undetectable
4dqbB-2issA:
17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iwz 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
SYNTHASE


(Homo sapiens)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 GLY A 234
ALA A 233
GLY A  48
ILE A  49
VAL A 302
None
0.97A 4dqbB-2iwzA:
undetectable
4dqbB-2iwzA:
13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2m1i PARVULIN-LIKE
PEPTIDYL-PROLYL
ISOMERASE


(Cenarchaeum
symbiosum)
PF13616
(Rotamase_3)
5 LEU A  16
ASP A  46
GLY A  48
ASP A  53
GLY A  57
None
0.91A 4dqbB-2m1iA:
undetectable
4dqbB-2m1iA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oej 2,3-DIKETO-5-METHYLT
HIOPENTYL-1-PHOSPHAT
E ENOLASE


(Geobacillus
kaustophilus)
PF00016
(RuBisCO_large)
PF02788
(RuBisCO_large_N)
5 LEU A 298
ALA A 294
GLY A 126
ILE A 130
VAL A 333
None
0.86A 4dqbB-2oejA:
undetectable
4dqbB-2oejA:
13.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
1.26A 4dqbB-2rkfA:
20.6
4dqbB-2rkfA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
0.45A 4dqbB-2rkfA:
20.6
4dqbB-2rkfA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
5 LEU A  35
ASP A  37
GLY A  39
ALA A  40
ASP A  41
None
0.26A 4dqbB-2rspA:
12.7
4dqbB-2rspA:
33.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vdc GLUTAMATE SYNTHASE
[NADPH] LARGE CHAIN


(Azospirillum
brasilense)
PF00310
(GATase_2)
PF01493
(GXGXG)
PF01645
(Glu_synthase)
PF04898
(Glu_syn_central)
6 LEU A1286
GLY A1273
ALA A1272
ASP A1291
VAL A1307
GLY A1324
None
1.38A 4dqbB-2vdcA:
undetectable
4dqbB-2vdcA:
6.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vn8 RETICULON-4-INTERACT
ING PROTEIN 1


(Homo sapiens)
PF08240
(ADH_N)
PF13602
(ADH_zinc_N_2)
5 LEU A 243
GLY A 248
ALA A 249
ASP A 250
ASP A 251
None
0.80A 4dqbB-2vn8A:
undetectable
4dqbB-2vn8A:
15.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xyb LACCASE

(Trametes
cinnabarina)
PF00394
(Cu-oxidase)
PF07731
(Cu-oxidase_2)
PF07732
(Cu-oxidase_3)
5 LEU A 353
GLY A 358
ALA A 359
VAL A 366
VAL A 349
None
0.98A 4dqbB-2xybA:
undetectable
4dqbB-2xybA:
16.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z2i PEPTIDYL-TRNA
HYDROLASE


(Mycobacterium
tuberculosis)
PF01195
(Pept_tRNA_hydro)
5 GLY A  47
ALA A  48
VAL A   8
GLY A  77
VAL A  61
None
0.97A 4dqbB-2z2iA:
undetectable
4dqbB-2z2iA:
18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z5x AMINE OXIDASE
[FLAVIN-CONTAINING]
A


(Homo sapiens)
PF01593
(Amino_oxidase)
5 LEU A 233
ALA A  29
VAL A 238
GLY A  22
ILE A  23
None
None
None
FAD  A 600 (-3.2A)
FAD  A 600 (-4.9A)
0.78A 4dqbB-2z5xA:
undetectable
4dqbB-2z5xA:
13.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zvi 2,3-DIKETO-5-METHYLT
HIOPENTYL-1-PHOSPHAT
E ENOLASE


(Bacillus
subtilis)
PF00016
(RuBisCO_large)
PF02788
(RuBisCO_large_N)
5 LEU A 301
ALA A 297
GLY A 129
ILE A 133
VAL A 335
None
0.86A 4dqbB-2zviA:
undetectable
4dqbB-2zviA:
13.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqp PROBABLE SECDF
PROTEIN-EXPORT
MEMBRANE PROTEIN


(Thermus
thermophilus)
PF02355
(SecD_SecF)
PF07549
(Sec_GG)
5 GLY A 327
ALA A 329
GLY A 274
ILE A 271
VAL A 693
None
0.80A 4dqbB-3aqpA:
undetectable
4dqbB-3aqpA:
9.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b1s FLAGELLAR
BIOSYNTHETIC PROTEIN
FLHB


(Aquifex
aeolicus)
PF01312
(Bac_export_2)
5 ALA B 270
VAL B 322
GLY B 287
ILE B 267
VAL B 320
None
0.94A 4dqbB-3b1sB:
undetectable
4dqbB-3b1sB:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c8t FUMARATE LYASE

(Chelativorans
sp. BNC1)
PF00206
(Lyase_1)
PF10397
(ADSL_C)
5 GLY A 341
ALA A 343
ASP A  27
GLY A 132
ILE A 129
None
0.97A 4dqbB-3c8tA:
undetectable
4dqbB-3c8tA:
11.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eeq PUTATIVE COBALAMIN
BIOSYNTHESIS PROTEIN
G HOMOLOG


(Sulfolobus
solfataricus)
PF01890
(CbiG_C)
PF11760
(CbiG_N)
5 LEU A 318
GLY A 219
ALA A 306
GLY A 250
ILE A 249
None
0.97A 4dqbB-3eeqA:
undetectable
4dqbB-3eeqA:
19.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fk4 RUBISCO-LIKE PROTEIN

(Bacillus cereus)
PF00016
(RuBisCO_large)
PF02788
(RuBisCO_large_N)
5 LEU A 299
ALA A 295
GLY A 127
ILE A 131
VAL A 334
None
0.86A 4dqbB-3fk4A:
undetectable
4dqbB-3fk4A:
12.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hag CAPSID PROTEIN

(Orthohepevirus
A)
PF03014
(SP2)
5 ALA A 419
VAL A 364
GLY A 424
ILE A 425
VAL A 410
None
0.93A 4dqbB-3hagA:
undetectable
4dqbB-3hagA:
11.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
5 GLY A 264
ALA A 265
ASP A 266
GLY A 460
ILE A 459
None
0.71A 4dqbB-3i5gA:
undetectable
4dqbB-3i5gA:
8.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iru PHOSHONOACETALDEHYDE
HYDROLASE LIKE
PROTEIN


(Oleispira
antarctica)
PF13419
(HAD_2)
5 LEU A  29
GLY A  21
ALA A  20
GLY A  56
VAL A  32
None
0.67A 4dqbB-3iruA:
undetectable
4dqbB-3iruA:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3it4 ARGININE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
ARGJ ALPHA CHAIN


(Mycobacterium
tuberculosis)
PF01960
(ArgJ)
5 LEU A  66
GLY A  92
ASP A  98
ILE A 130
VAL A  65
None
0.85A 4dqbB-3it4A:
undetectable
4dqbB-3it4A:
16.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jv7 ADH-A

(Rhodococcus
ruber)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 211
GLY A 216
ALA A 217
ASP A 218
ILE A 190
None
0.76A 4dqbB-3jv7A:
undetectable
4dqbB-3jv7A:
16.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kje CO
DEHYDROGENASE/ACETYL
-COA SYNTHASE
COMPLEX, ACCESSORY
PROTEIN COOC


(Carboxydothermus
hydrogenoformans)
PF01656
(CbiA)
6 ASP A 138
GLY A  36
ASP A  39
GLY A 142
ILE A 143
VAL A 160
None
1.24A 4dqbB-3kjeA:
undetectable
4dqbB-3kjeA:
20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mmp ELONGATION FACTOR TU
2, ELONGATION FACTOR
TS


(Escherichia
coli)
PF00009
(GTP_EFTU)
PF00889
(EF_TS)
PF03143
(GTP_EFTU_D3)
PF03144
(GTP_EFTU_D2)
5 GLY A  16
ALA A  17
ASP A  21
GLY A 126
ILE A 125
None
0.98A 4dqbB-3mmpA:
undetectable
4dqbB-3mmpA:
9.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  48
None
0.64A 4dqbB-3mwsA:
19.7
4dqbB-3mwsA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.18A 4dqbB-3mwsA:
19.7
4dqbB-3mwsA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
VAL A  82
None
0.48A 4dqbB-3mwsA:
19.7
4dqbB-3mwsA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
VAL A  82
None
0.46A 4dqbB-3mwsA:
19.7
4dqbB-3mwsA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pty ARABINOSYLTRANSFERAS
E C


(Mycobacterium
tuberculosis)
PF14896
(Arabino_trans_C)
5 LEU A 960
GLY A 889
ALA A 888
GLY A 921
VAL A 885
None
0.92A 4dqbB-3ptyA:
undetectable
4dqbB-3ptyA:
13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qbd 3-DEHYDROQUINATE
SYNTHASE


(Mycobacterium
tuberculosis)
PF01761
(DHQ_synthase)
6 LEU A  48
GLY A 106
ALA A 109
ASP A 111
VAL A  43
GLY A  77
None
NAD  A 400 (-3.1A)
None
NAD  A 400 (-3.1A)
None
None
1.32A 4dqbB-3qbdA:
undetectable
4dqbB-3qbdA:
16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qi7 PUTATIVE
TRANSCRIPTIONAL
REGULATOR


(Clostridioides
difficile)
PF12683
(DUF3798)
5 LEU A 152
ASP A 147
GLY A 123
ILE A 103
VAL A 156
None
0.92A 4dqbB-3qi7A:
undetectable
4dqbB-3qi7A:
14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
6 LEU A  30
ASP A  32
GLY A  34
ALA A  35
VAL A  39
GLY A  56
None
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-3.4A)
0.59A 4dqbB-3slzA:
11.0
4dqbB-3slzA:
25.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.23A 4dqbB-3t3cA:
18.7
4dqbB-3t3cA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tqd 3-DEOXY-MANNO-OCTULO
SONATE
CYTIDYLYLTRANSFERASE


(Coxiella
burnetii)
PF02348
(CTP_transf_3)
5 LEU A 242
GLY A  18
ASP A  12
ILE A  30
VAL A 236
None
0.98A 4dqbB-3tqdA:
undetectable
4dqbB-3tqdA:
15.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
1.15A 4dqbB-3ttpA:
19.3
4dqbB-3ttpA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
0.47A 4dqbB-3ttpA:
19.3
4dqbB-3ttpA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
0.30A 4dqbB-3u7sA:
19.7
4dqbB-3u7sA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
None
0.38A 4dqbB-3uhlA:
16.3
4dqbB-3uhlA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zyx AMINE OXIDASE
[FLAVIN-CONTAINING]
B


(Homo sapiens)
PF01593
(Amino_oxidase)
5 LEU A 224
ALA A  20
VAL A 229
GLY A  13
ILE A  14
None
None
None
FAD  A 600 (-3.4A)
FAD  A 600 (-4.8A)
0.81A 4dqbB-3zyxA:
undetectable
4dqbB-3zyxA:
14.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bo6 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
REDUCTASE FABG


(Pseudomonas
aeruginosa)
PF13561
(adh_short_C2)
5 LEU A 117
GLY A  91
ALA A  90
GLY A  18
ILE A  17
None
0.94A 4dqbB-4bo6A:
undetectable
4dqbB-4bo6A:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hbk ALDO-KETO REDUCTASE
FAMILY 1, MEMBER B4
(ALDOSE REDUCTASE)


(Schistosoma
japonicum)
PF00248
(Aldo_ket_red)
5 LEU A 244
GLY A  16
GLY A  38
ILE A  37
VAL A 270
None
0.97A 4dqbB-4hbkA:
undetectable
4dqbB-4hbkA:
19.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ida RIPENING-INDUCED
PROTEIN


(Fragaria vesca)
PF08240
(ADH_N)
PF13602
(ADH_zinc_N_2)
5 LEU A 203
GLY A 208
ALA A 209
ASP A 210
ILE A 179
None
0.83A 4dqbB-4idaA:
undetectable
4dqbB-4idaA:
16.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jyj ENOYL-COA
HYDRATASE/ISOMERASE


(Novosphingobium
aromaticivorans)
PF00378
(ECH_1)
5 ALA A 120
ASP A 121
GLY A  54
ILE A  19
VAL A 105
None
0.95A 4dqbB-4jyjA:
undetectable
4dqbB-4jyjA:
18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4maa PUTATIVE
BRANCHED-CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN


(Pseudomonas
protegens)
PF13458
(Peripla_BP_6)
5 LEU A 105
GLY A 128
ALA A 129
ASP A 130
GLY A 179
GOL  A 503 ( 4.4A)
GOL  A 503 (-3.7A)
None
None
None
0.99A 4dqbB-4maaA:
undetectable
4dqbB-4maaA:
13.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  48
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-4.8A)
0.65A 4dqbB-4njvA:
20.3
4dqbB-4njvA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
1.21A 4dqbB-4njvA:
20.3
4dqbB-4njvA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
None
0.44A 4dqbB-4njvA:
20.3
4dqbB-4njvA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
None
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
0.47A 4dqbB-4njvA:
20.3
4dqbB-4njvA:
82.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ry9 PERIPLASMIC BINDING
PROTEIN/LACI
TRANSCRIPTIONAL
REGULATOR


(Verminephrobacter
eiseniae)
PF13407
(Peripla_BP_4)
5 LEU A 105
ASP A  86
GLY A  39
ILE A  96
VAL A 109
None
0.98A 4dqbB-4ry9A:
undetectable
4dqbB-4ry9A:
16.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tqk LECTIN 2

(Agrocybe
aegerita)
PF13517
(VCBS)
5 ASP A 345
GLY A 350
ASP A 290
VAL A 343
GLY A 371
None
0.86A 4dqbB-4tqkA:
undetectable
4dqbB-4tqkA:
14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ttp DEPHOSPHO-COA KINASE

(Legionella
pneumophila)
PF01121
(CoaE)
6 LEU A 168
ALA A 175
ASP A 176
ASP A 177
GLY A  12
ILE A 118
None
1.04A 4dqbB-4ttpA:
undetectable
4dqbB-4ttpA:
18.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xib E3 UBIQUITIN-PROTEIN
LIGASE MIB1


(Homo sapiens)
PF00569
(ZZ)
PF06701
(MIB_HERC2)
6 LEU A 215
GLY A 154
ALA A 155
ASP A 220
GLY A 223
VAL A 207
None
1.38A 4dqbB-4xibA:
undetectable
4dqbB-4xibA:
13.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xky DIHYDRODIPICOLINATE
SYNTHASE


(Bacteroides
thetaiotaomicron)
PF00701
(DHDPS)
5 LEU A  94
GLY A  99
ALA A 100
ASP A 101
ILE A  69
None
None
None
MHO  A   1 ( 3.2A)
None
0.98A 4dqbB-4xkyA:
undetectable
4dqbB-4xkyA:
15.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 LEU A  30
ASP A  32
GLY A  34
ALA A  35
ASP A  36
GLY A  58
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
0.49A 4dqbB-4ydfA:
12.5
4dqbB-4ydfA:
32.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 LEU A  30
ASP A  32
GLY A  34
ALA A  35
ASP A  36
VAL A  39
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
None
0.49A 4dqbB-4ydfA:
12.5
4dqbB-4ydfA:
32.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
None
0.62A 4dqbB-5b18A:
18.4
4dqbB-5b18A:
72.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ej1 PUTATIVE CELLULOSE
SYNTHASE


(Rhodobacter
sphaeroides)
PF00535
(Glycos_transf_2)
PF03552
(Cellulose_synt)
PF07238
(PilZ)
5 LEU A 688
GLY A 614
VAL A 681
GLY A 655
ILE A 637
None
C2E  A 919 (-3.4A)
None
None
None
0.90A 4dqbB-5ej1A:
undetectable
4dqbB-5ej1A:
9.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g5g PUTATIVE XANTHINE
DEHYDROGENASE YAGR
MOLYBDENUM-BINDING
SU SUBUNIT


(Escherichia
coli)
PF00941
(FAD_binding_5)
PF03450
(CO_deh_flav_C)
5 LEU B 172
ALA B  94
ASP B 164
VAL B 167
ILE B 227
None
None
FAD  B 321 (-3.9A)
None
None
0.97A 4dqbB-5g5gB:
undetectable
4dqbB-5g5gB:
16.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hs0 ANKYRIN DOMAIN
PROTEIN ANK1C4_7


(synthetic
construct)
PF12796
(Ank_2)
5 LEU A 121
GLY A 126
ALA A 127
ASP A 128
VAL A  86
None
0.94A 4dqbB-5hs0A:
undetectable
4dqbB-5hs0A:
18.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.18A 4dqbB-5t2zA:
20.0
4dqbB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
None
0.44A 4dqbB-5t2zA:
20.0
4dqbB-5t2zA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5weo GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT
CHIMERA


(Mus musculus;
Rattus
norvegicus)
PF00060
(Lig_chan)
PF00822
(PMP22_Claudin)
PF01094
(ANF_receptor)
PF10613
(Lig_chan-Glu_bd)
5 LEU A1195
GLY A1015
ALA A1016
ILE A1187
VAL A1194
None
0.87A 4dqbB-5weoA:
undetectable
4dqbB-5weoA:
8.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wtf VP0
VP1


(Hepatovirus A)
PF00073
(Rhv)
PF12944
(HAV_VP)
5 GLY A 213
ALA A 214
ASP B 132
VAL B 129
GLY B 136
None
0.99A 4dqbB-5wtfA:
undetectable
4dqbB-5wtfA:
16.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
7 LEU A  28
ASP A  30
GLY A  32
ALA A  33
ASP A  34
GLY A  58
VAL A  99
None
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 (-3.4A)
None
0.67A 4dqbB-6fivA:
15.3
4dqbB-6fivA:
28.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6grw -

(-)
no annotation 5 LEU A 247
GLY A 277
ALA A 276
GLY A 265
ILE A 287
None
0.81A 4dqbB-6grwA:
undetectable
4dqbB-6grwA:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
1.47A 4dqbB-6upjA:
18.1
4dqbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
0.71A 4dqbB-6upjA:
18.1
4dqbB-6upjA:
49.49